The Global Burden of Gynecological Diseases from 1990 to 2019

被引:2
作者
Cao, Yukun [1 ]
Guo, Yufeng [2 ]
Long, Zhiping [1 ]
Wu, Yi [1 ]
Pei, Bing [1 ]
Ye, Jingyu [1 ]
Zhang, Min [1 ]
Yuan, Heli [1 ]
Jia, Yanjie [1 ]
Liu, Xiao [1 ]
Wang, Fan [1 ]
Zhao, Yashuang [1 ]
机构
[1] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol, 157 Baojian Rd, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Heilongjiang, Peoples R China
关键词
POLYCYSTIC-OVARY-SYNDROME; SYNDROME PCOS; WOMEN; PATHOGENESIS; PREVALENCE;
D O I
10.1016/j.amepre.2024.06.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Gynecological diseases ranked second among new cases of noncommunicable diseases in women of reproductive age in 1990 and 2019 globally. The aim of this study was to estimate the disease burden of gynecological diseases and describe their trends in women of all ages from 1990 to 2019. Methods: Using data from the Global Burden of Diseases, Injuries and Risk Factors Study (GBD 2019), authors examined the incidence, disability-adjusted life years, and deaths from gynecological diseases by age in 204 countries and territories worldwide from 1990 to 2019. Analyses were conducted in 2022. Results: Globally, the age-standardized incidence rate and age-standardized disability-adjusted life year rate (ASDR) of gynecological diseases decreased by - 0.176% and - 0.245%, respectively from 1990 to 2019. Low socioeconomic development index countries had the highest age-standardized incidence rate and ASDR in 2019. The age-specific incidence rate of gynecological diseases in women aged 15 - 29 years increased from 1990 to 2019, and the 20-24-year age group increased the greatest by 0.21%. Polycystic ovary syndrome and other types of benign disorders contributed to the major increase. Conclusions: Although the disease burden of gynecological diseases decreased slightly between 1990 and 2019 globally, it remained highest in low socioeconomic development index countries. The disease burden in 20-24-year age group exhibited the fastest growth, with polycystic ovary syndrome and other types of benign disorders playing a significant role. Urgent and effective measures should be taken to target different age groups, types of gynecological disease, and regions with high disease burdens. Am J Prev Med 2024;67(5):698-704. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 27 条
  • [21] Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]
  • [22] Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women
    Takeda, T.
    Tasaka, K.
    Sakata, M.
    Murata, Y.
    [J]. ARCHIVES OF WOMENS MENTAL HEALTH, 2006, 9 (04) : 209 - 212
  • [23] Fertility and infertility: Definition and epidemiology
    Vander Borght, Melodie
    Wyns, Christine
    [J]. CLINICAL BIOCHEMISTRY, 2018, 62 : 2 - 10
  • [24] Vos T, 2020, LANCET, V396, P1562
  • [25] Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6
  • [26] Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
    Witchel, Selma Feldman
    Oberfield, Sharon E.
    Pena, Alexia S.
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (08) : 1545 - 1573
  • [27] Premenstrual syndrome
    Yonkers, Kimberly Ann
    O'Brien, P. M. Shaughn
    Eriksson, Elias
    [J]. LANCET, 2008, 371 (9619) : 1200 - 1210